Home Educational Resources Choosing Anti-PD1 Antibodies

How To Choose An Anti-PD-1 Antibody For Your Research

PD-1 Introduction

Programmed death-1 (PD-1) is an inhibitory receptor expressed on T-cells that promotes apoptosis of inflammatory T-cells and inhibits apoptosis of anti-inflammatory regulatory T-cells, thereby promoting self-tolerance and preventing autoimmune diseases. To evade immune surveillance, tumor cells often exploit this system by over-expressing PD-L1, the ligand which binds to and activates PD-1. Anti-PD-1 monoclonal antibodies are used to block the binding of PD-L1 to PD-1 which allows the immune system to find and kill tumor cells.

Anti-PD-1 Antibody Reactivity

The first step in deciding which anti-PD-1 antibody fits your research needs is to identify which species reactivity is needed for your experimental model. Bio X Cell offers anti-mouse and anti-human PD-1 antibodies. Which to choose is based on your experimental model. If you are using mice expressing mouse PD-1 you want to choose an anti-mouse PD-1 antibody. If you are using human cells in culture or humanized mice expressing human PD-1 then you want to choose an anti-human PD-1 antibody.

Anti-mouse PD-1 Antibody Clones

Detailed Comparison of anti-mouse PD-1 Antibody Clones

Recombinant anti-mouse PD-1 Antibody Clones

Bio X Cell also offers recombinant chimeric versions of our three anti-mouse PD-1 antibody clones. RecombiMAbā„¢ antibodies are provided as chimeric antibodies with mouse constant regions instead of the typical rat or hamster constant regions. This ensures reduced immunogenicity in sensitive mouse models. Select RecombiMAbā„¢ antibodies are also available in multiple Fc silenced versions. These Fc silenced versions have mutations in the Fc fragment of the antibody rendering them unable to bind to endogenous Fcγ receptors.

Detailed Comparison of Recombinant anti-mouse PD-1 Antibody Clones

Anti-human PD-1 Antibody Clones

Bio X Cell also offers multiple anti-human PD-1 antibodies for use in humanized mouse models or immunoassays. These include clones J116 and J110 and Pembrolizumab and Nivolumab biosimilar antibodies.

Detailed Comparison of anti-human PD-1 Antibody Clones